Amphastar Pharmaceuticals Inc Trading Down 3.5 percent on Jan 16
| AMPH Stock | USD 32.79 0.40 1.21% |
Under 62% of Amphastar's investor base is looking to short. The analysis of overall sentiment of trading Amphastar P stock suggests that many investors are alarmed at this time. Amphastar's investing sentiment shows overall attitude of investors towards Amphastar P.
Amphastar |
Shares of Amphastar Pharmaceuticals Inc fell 3.50 percent in mid-day trading on Jan 16. The stock reached an intraday low of 34.60, before recovering slightl
Read at gurufocus.com
 |
Amphastar Fundamental Analysis
We analyze Amphastar's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Amphastar is currently under evaluation in target price category among its peers.
Amphastar P Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amphastar stock to make a market-neutral strategy. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics with similar companies.
Peers
Amphastar Related Equities
| PBH | Prestige Brand | 14.78 | ||||
| PAHC | Phibro Animal | 9.88 | ||||
| COLL | Collegium Pharmaceutical | 0.78 | ||||
| ANIP | ANI Pharmaceuticals | 0.64 | ||||
| EVO | Evotec SE | 0.21 | ||||
| ALKS | Alkermes Plc | 0.25 | ||||
| NBIX | Neurocrine Biosciences | 0.46 | ||||
| EOLS | Evolus | 1.18 | ||||
| SUPN | Supernus Pharmaceuticals | 1.60 | ||||
| PCRX | Pacira BioSciences, | 3.06 | ||||
| IRWD | Ironwood Pharmaceuticals | 8.06 |
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |